Rev Med Suisse. 2023 Oct 25;19(847):2002-2006. doi: 10.53738/REVMED.2023.19.847.2002.
ABSTRACT
Acute heart failure is a leading cause of hospitalisations with an increasing economic and public health burden. Management of acute heart failure involves the use of diuretics to treat congestion and improve morbimortality. Despite current guidelines, numerous patients maintain congestion and often leave the hospital setting with incomplete volume depletion, leading to an increased risk of rehospitalisation. A recent multicentric randomised controlled trial studied the administration of acetazolamide in addition to standard care with loop diuretics in the acute setting. There was a significantly faster decongestion, based on a pragmatic clinical score, with very few side effects.
PMID:37878100 | DOI:10.53738/REVMED.2023.19.847.2002